NeogenNEOG
About: Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, Neogen performs diagnostics to detect unintended substances in food and animal feed, such as pathogens, allergens, and drug residues, for food and feed processing companies. In animal safety, Neogen sells veterinary instruments, pharmaceuticals, disinfectants, and genomics tests for animals, including cattle, horses, and canines. Sales in the United States account for maximum revenue, and it also has its presence in United Kingdom and other countries.
Employees: 1,315
Fund manager confidence
Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)
288% more call options, than puts
Call options by funds: $3.37M | Put options by funds: $868K
10% more repeat investments, than reductions
Existing positions increased: 127 | Existing positions reduced: 115
0% more funds holding in top 10
Funds holding in top 10: 3 [Q2] → 3 (+0) [Q3]
2% less capital invested
Capital invested by funds: $4.02B [Q2] → $3.95B (-$70.7M) [Q3]
3% less funds holding
Funds holding: 344 [Q2] → 332 (-12) [Q3]
10.21% less ownership
Funds ownership: 118.66% [Q2] → 108.45% (-10.21%) [Q3]
31% less first-time investments, than exits
New positions opened: 27 | Existing positions closed: 39
Research analyst outlook
We haven’t received any recent analyst ratings for NEOG.
Financial journalist opinion
